Pretargeted Radioimmunotherapy
Sponsors
Fred Hutchinson Cancer Center
Conditions
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaMixed Phenotype Acute LeukemiaMyelodysplastic Syndrome With Excess BlastsMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic Syndrome
Phase 1
Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
CompletedNCT00988715
Start: 2010-04-21Updated: 2017-08-30
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
RecruitingNCT03128034
Start: 2017-10-24End: 2029-03-31Target: 75Updated: 2026-06-22